Several mechanisms may be involved in spontaneous C activation in CLL patients, including AP activation related to reduced expression of CR1 and CR2 on malignant B cells [20], reduced expression of the C1 inhibitor [18] and the presence of cholesterol crystals [13,14]. The gene discussed is CR2; the disease is B-cell chronic lymphocytic leukemia.